Abstract
Chronic lung disease in the extremely preterm baby is still a major complication in neonatal intensive care. Perinatal (ante- and neonatal) glucocorticoids are widely used to prevent severe infant respiratory distress syndrome and/or to reduce chronic lung disease respectively. A review of the literature regarding the cardiovascular side effects of antenatal and neonatal glucocorticoids is presented here.
Original language | English (US) |
---|---|
Pages (from-to) | 190-197 |
Number of pages | 8 |
Journal | Current Pediatric Reviews |
Volume | 3 |
Issue number | 3 |
DOIs | |
State | Published - Aug 2007 |
Keywords
- Betamethasone
- Chronic lung disease
- Hypertrophy
- Protein/DNA ratio
- Respiratory Distress Syndrome
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health